The 20 Best Tongue Cancer Doctors Near Me in Bethesda, MD

Wojtek Mydlarz, director of Johns Hopkins Head and Neck Surgery in the National Capital Region, specializes in the treatment of benign and malignant tumors of the head and neck, including the upper aerodigestive tract, salivary glands, skull base, thyroid, skin and soft tissue. Dr. Mydlarz is a medical officer and a clinical and research collaborator in the head and neck surgery branch of the National Institutes of Health (NIH). His research interests include evaluating both surgical and nonsurgical treatment outcomes in patients with head and neck cancer. He is interested in the complex molecular biology of head and neck cancer, as well as potential clinical applications of novel targeted cancer therapies. He is actively involved in clinical trial development and implementation at the NIH and Johns Hopkins. After earning his medical degree from the Johns Hopkins University School of Medicine, Dr. Mydlarz completed his internship and residency in otolaryngology–head and neck surgery at The Johns Hopkins Hospital. Additionally, he completed a Science of Clinical Investigation Training Program at Johns Hopkins Bloomberg School of Public Health and specialized fellowship training in head and neck surgical oncology at the University of Texas MD Anderson Cancer Center. Dr. Mydlarz has contributed to numerous professional publications, authored a variety of articles and book chapters, and has been invited to give many lectures. He serves on the editorial board for Oral Oncology and Laryngoscope Investigative Otolaryngology, and is a journal reviewer for Oral Oncology, Head and Neck, Laryngoscope and JAMA Otolaryngology–Head and Neck Surgery. Dr. Mydlarz is rated as an Advanced provider by MediFind in the treatment of Tongue Cancer. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Head and Neck Squamous Cell Carcinoma (HNSCC), Tongue Cancer, Salivary Gland Tumors, Laryngectomy, and Tissue Biopsy. Dr. Mydlarz is board certified in Head And Neck Surgery.

Brandi Page, M.D., is an assistant professor of radiation oncology and molecular sciences for Johns Hopkins Radiation Oncology Department at Suburban Hospital and a radiation oncologist at the Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital. Dr. Page has expertise in treating all types of cancer and, for the last several years, has become a highly sought-after specialist in the National Capitol Region (NCR-MD/DC/VA) for her expertise in treating head and neck and brain/central nervous system tumors. In Dr. Page's role with Johns Hopkins she has brought new complex radiotherapy services to the facility and facilitated the team building environment for collaborating practitioners and caregivers in the region. Dr. Page also serves on the Cancer Committee for Sibley and Suburban Hospitals for the American Cancer Society, which brings together multidisciplinary care providers to collaborate on initiatives for continued excellence. She is a teaching faculty member at the Johns Hopkins School of Medicine for medical students, residents and fellows, is the current director of radiation oncology fellowships, initiating and growing the first radiation oncology fellowship at the institution a year after the initiation of the proton center. Dr. Page earned her medical degree at Albany Medical College, completed residency in radiation oncology at the Huntsman Cancer Institute at the University of Utah, and fellowship in translational radiation oncology at Wake Forest University Medical Center, where she earned the Service Excellence in Patient Care Award. At Johns Hopkins she has won awards for clinical excellence nominated by peers many years in a row and a Faculty of the Year award for her teaching efforts. Dr. Page is a member of the American Society of Therapeutic Radiation Oncology, a diplomate of the American Board of Radiology, and a Fellow of the American College of Radiation Oncology. Dr. Page has served on the Board of Directors for Radiating Hope and currently serves on the Board of Directors for Courage Unmasked/911-4-HNC (a Head and Neck Cancer support organization). Dr. Page frequently serves as a sought after reviewer for peer reviewed articles and has served as the Continuing Medical Education Editor for the International Journal of Radiation Oncology Biology Physics (IJROBP). Dr. Page believes the best way to empower patients is with knowledge and partnership and she looks forward to partnering with patients in treating their condition, and helping them successfully get through their treatment and maximize opportunities for a happy healthy life after treatment. Make A Gift LinkedIn https://www.linkedin.com/in/brandi-page-968650b0. Dr. Page is rated as an Experienced provider by MediFind in the treatment of Tongue Cancer. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Brain Tumor, Throat Cancer, Laryngeal Cancer, Glioma, and Gamma Knife Radiosurgery. Dr. Page is board certified in American Board Of Radiology.

Shaun Desai is an Otolaryngologist and a Plastic Surgeon practicing medicine in Bethesda, Maryland. He has been practicing medicine for over 17 years. Dr. Desai is rated as an Experienced provider by MediFind in the treatment of Tongue Cancer. His clinical expertise encompasses Facial Paralysis, Aseptic and Alopecic Nodules of Scalp (AANS), Melanoma, Osteotomy, and Bone Graft. Dr. Desai is board certified in American Board Of Facial Plastic And Reconstructive Surgery and Head And Neck Surgery.

Nyall London has a unique clinical practice focused on the care of patients with sinonasal and skull base cancers. As one of the few surgeons trained in both head and neck cancer surgery, as well as rhinology and skull base surgery, he offers patients comprehensive sinonasal tumor surgical care, including open and endoscopic approaches as well as neck dissection surgery. Dr. London has developed notable patient education events about the multidisciplinary and long-term care of patients with sinonasal malignancies. Additionally, he is an innovator of clinical trials for these rare tumors, with open clinical trial options available and multiple others in development. Internationally recognized for his expertise in the care of patients with sinonasal and skull base cancers, Dr. London was an associate editor for the first international consensus statement on sinonasal tumors, and was appointed president of the International Network for Sinonasal Cancer Research (2024–26). He directs a research laboratory at the National Cancer Institute/National Institutes of Health focused on therapeutic advances and mechanisms of sinonasal tumorigenesis. Dr. London has published more than 130 peer-reviewed research articles, reviews and book chapters, including co-first author publications in Nature, Nature Medicine, Science Translational Medicine and Nature Cell Biology. He earned his medical and doctoral degrees from the University of Utah, and completed his residency in otolaryngology–head and neck surgery at Johns Hopkins. He also accomplished a fellowship in open and endoscopic head and neck and skull base surgery at The Ohio State University, under the direction of Dr. Ricardo Carrau. Dr. London is rated as an Experienced provider by MediFind in the treatment of Tongue Cancer. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Olfactory Neuroblastoma, Sinus Cancer, Teratocarcinosarcoma, Endoscopy, and Craniectomy. Dr. London is board certified in Head And Neck Surgery.

Karim Boudadi, M.D., is a medical oncologist and hematologist with the Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital in Washington, D.C., and an assistant professor in the Department of Oncology at Johns Hopkins University School of Medicine. Listen to Dr. Boudadi’s Cancer Matters podcast episode to learn more about his work. Dr. Boudadi has expertise in treating cancers of the head and neck, including salivary gland cancers, as well as cancers of the esophagus, and bone and soft tissue sarcomas. Having completed dual training in medical oncology and hematology at Johns Hopkins University, Dr. Boudadi also treats patients with benign hematologic conditions or non-cancer related blood disorders, such as anemia, low blood counts, bleeding disorders, and clotting disorders. Dr. Boudadi earned his medical degree from the University of Rochester School of Medicine. He completed a residency in internal medicine at the University of Michigan in Ann Arbor, MI, and went on to serve as a clinical lecturer in the Department of Internal Medicine at the University of Michigan Medical School before joining Johns Hopkins. He then completed dual fellowship training in both hematology and medical oncology at the Johns Hopkins University School of Medicine. Dr. Boudadi's research during his fellowship focused on prostate cancer and immunotherapy. Dr. Boudadi is a member of the American Society of Clinical Oncology, the American Society of Hematology, the American College of Physicians, and the American Medical Association. He is also a member of the Hematology and Oncology Fellowship Selection Committee at The Johns Hopkins University School of Medicine. Dr. Boudadi has extensive clinical trial development experience and has published his work in peer-reviewed journals. His primary research interest is immunotherapy. Recent News Articles and Media Coverage Cancer Matters Podcast: Dr. Bill Nelson discussing the treatment of HPV related head and neck cancers, Johns Hopkins Kimmel Cancer Center Podcasts (May 23, 2019). Dr. Boudadi is rated as an Experienced provider by MediFind in the treatment of Tongue Cancer. He is also highly rated in 21 other conditions, according to our data. His clinical expertise encompasses Glioma, Mesenchymoma, Undifferentiated Pleomorphic Sarcoma, Gastrointestinal Stromal Tumor, and Prostatectomy. Dr. Boudadi is board certified in American Board Of Internal Medicine.

"Dr. Rachit Kumar is a radiation oncologist specializing in genitourinary and gastrointestinal cancers. He is dedicated to patient-centered care, finding the most effective outcome for each patient and using the latest advances to minimize treatment time and side-effects. Dr. Kumar is frequently published in peer-reviewed journals on new methods of radiation therapy and the benefits to patient outcomes. He is a member of the Johns Hopkins Kimmel Cancer Center and treats patients at both Sibley Memorial Hospital and Suburban Hospital. Selected Publications Kumar R, Tchelebi LT, Anker CJ, Sharma N, Bianchi NA, Dragovic J, Goodman KA, Herman JM, Jiang Y, Jones WE, Kenney TJ, Lee P, Kundranda MK, Russo S, Small W, Suh WW, Yee N, and Jabbour SK. “American Radium Society (ARS) Appropriateness Use Criteria (AUC) for Loco-Regional Gastric Adenocarcinoma: Systemic Review and Guidelines.” American Journal of Clinical Oncology. 2022 Sep 1;45(9):391-402. Rooney MK, Traube B, Khan MK, Kumar R, and Walker GV. “Factors associated with image guided radiation therapy image rejection in a multi-site institution.” JCO Oncology Practice. Tang C, Hoffman KE, Allen PK, Gabel M, Schreiber D, Choi S, Chapin BF, Nguyen QN, Davis JW, Frank SJ, Navai N, McGuire SE, Anscher M, Pisters L, Pettaway CA, Kumar R, Linson P, Tripuraneni P, Tomaszewski JJ, Patel AB, Augspurger M, and Kuban DA. “Contemporary Prostate Cancer Treatment Choices in Multidisciplinary Clinics Referenced to National Trends.” Cancer. Tang C, Lei X, Smith GL, Pan HY, Hoffman K, Kumar R, Chapin BF, Shih YC, Frank SJ, and Smith BD. ""Influence of Geography on Prostate Cancer Treatment Coice: An Analysis of the National Medicare Database."" International Journal of Radiation Oncology Biology Physics. Tang C, Sherry AD, Haymaker C, Bathala T, Liu S, Fellman B, Aparicio A, Zurita-Saavedra A, Chun S, Reddy J, Choi S, Ghia A, McGuire S, Efstathiou E, Wang J, Wang J, Tu SM, Pilie P, Kovitz C, Kumar R, Roberts T, Borghero Y, Shi Z, Chapin B, Gomez D, Wistuba I, Corn and PG. “Addition of local consolidative therapy to intermittent hormone therapy for oligometastatic prostate cancer (EXTEND): a multicenter randomized phase II basket trial.” JAMA Oncology.". Dr. Kumar is rated as an Experienced provider by MediFind in the treatment of Tongue Cancer. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Familial Pancreatic Cancer, Pancreatoblastoma, and Prostate Cancer. Dr. Kumar is board certified in American Board Of Radiology.

Matthew Lee Pierce is an Otolaryngologist practicing medicine in Washington, Washington, D.c.. Dr. Lee Pierce is rated as a Distinguished provider by MediFind in the treatment of Tongue Cancer. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Laryngeal Cancer, Oral Squamous Cell Carcinoma, Tongue Cancer, Laryngectomy, and Thyroidectomy.

Nicholas Farrell is a Hematologist Oncology provider practicing medicine in Bethesda, Maryland. Dr. Farrell is rated as an Experienced provider by MediFind in the treatment of Tongue Cancer. He is also highly rated in 47 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Childhood Iron Deficiency Anemia, Pleuropulmonary Blastoma, and Iron Deficiency Anemia. Dr. Farrell is board certified in American Board Of Internal Medicine.

Dr. Mark Markowski is a medical oncologist at the Kimmel Cancer Center at Sibley Memorial Hospital, as well as an Associate Professor in the Department of Oncology at Johns Hopkins University School of Medicine. Dr. Markowski participates in multidisciplinary clinics at Sibley and The Johns Hopkins Hospital, and sees patients in the genitourinary clinics of both hospitals. Dr. Markowski treats numerous types of cancers, with a specialty in prostate and kidney cancers. Dr. Markowski earned his medical degree and Ph.D. in tumor biology at Georgetown University School of Medicine. He completed a residency in internal medicine at Columbia University, followed by a medical oncology fellowship at Johns Hopkins Hospital. Dr. Markowski previously served as a research associate at the Lombardi Comprehensive Cancer Center at Georgetown University. His research interests focus on early phase drug development for prostate cancer, as well a non-castrating therapies for patients with metastatic disease. Dr. Markowski is currently conducting research with funding from a Department of Defense Prostate Cancer Research Program Award and a Challenge Award from the Prostate Cancer Foundation, which focuses on new treatment strategies for prostate cancer patients. Dr. Markowski is rated as an Experienced provider by MediFind in the treatment of Tongue Cancer. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Renal Cell Carcinoma (RCC), Familial Prostate Cancer, Hormone Replacement Therapy (HRT), and Prostatectomy.

Bruce Davidson is an Otolaryngologist practicing medicine in Washington, Washington, D.c.. Dr. Davidson is rated as an Advanced provider by MediFind in the treatment of Tongue Cancer. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Salivary Gland Tumors, Thyroid Cancer, Anaplastic Thyroid Cancer, Thyroidectomy, and Laryngectomy.

Thomas Winkler is a General Surgeon practicing medicine in Chevy Chase, Maryland. Dr. Winkler is rated as an Experienced provider by MediFind in the treatment of Tongue Cancer. He is also highly rated in 28 other conditions, according to our data. His clinical expertise encompasses DFNB1, Jones Syndrome, Palatal Myoclonus, and Ozena.

Ravi Chandra is a Radiation Oncologist practicing medicine in Rockville, Maryland. Dr. Chandra is rated as an Experienced provider by MediFind in the treatment of Tongue Cancer. His clinical expertise encompasses Laryngeal Cancer, Throat Cancer, Lung Cancer, and Oral Squamous Cell Carcinoma.

Jonathan Peter is an Otolaryngologist practicing medicine in Mclean, Virginia. Dr. Peter is rated as an Experienced provider by MediFind in the treatment of Tongue Cancer. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Salivary Duct Stones, Mikulicz Disease, Sialadenitis, Gastrostomy, and Laryngectomy.

Timothy Deklotz is an Otolaryngologist practicing medicine in Washington, Washington, D.c.. Dr. Deklotz is rated as an Experienced provider by MediFind in the treatment of Tongue Cancer. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Teratocarcinosarcoma, Olfactory Neuroblastoma, Fibrous Dysplasia, Endoscopic Transnasal Transsphenoidal Surgery, and Nerve Decompression.

Michael Reilly is a Plastic Surgeon and an Otolaryngologist practicing medicine in Washington, Washington, D.c.. Dr. Reilly is rated as an Experienced provider by MediFind in the treatment of Tongue Cancer. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Facial Paralysis, Bell's Palsy, Recurrent Peripheral Facial Palsy, and Herpes Zoster Oticus.

Pamela Randolph is a Radiation Oncologist practicing medicine in Washington, Washington, D.c.. Dr. Randolph is rated as an Experienced provider by MediFind in the treatment of Tongue Cancer. She is also highly rated in 30 other conditions, according to our data. Her clinical expertise encompasses Posterior Fossa Tumor, Anal Cancer, Small Cell Lung Cancer (SCLC), and Lung Cancer.

Peter Ahn is a Radiation Oncologist practicing medicine in Washington, Washington, D.c.. Dr. Ahn is rated as an Experienced provider by MediFind in the treatment of Tongue Cancer. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Laryngeal Cancer, Sinus Cancer, Throat Cancer, and Teratocarcinosarcoma.

Matthew Witek is a Hematologist practicing medicine in Washington, Washington, D.c.. He has been practicing medicine for over 17 years. Dr. Witek is rated as an Advanced provider by MediFind in the treatment of Tongue Cancer. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Laryngeal Cancer, Throat Cancer, Head and Neck Squamous Cell Carcinoma (HNSCC), Salivary Gland Tumors, and Gastrostomy.

Irina Veytsman is a Hematologist and an Oncologist practicing medicine in Washington, Washington, D.c.. Dr. Veytsman is rated as an Advanced provider by MediFind in the treatment of Tongue Cancer. She is also highly rated in 21 other conditions, according to our data. Her clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and Squamous Cell Lung Carcinoma.

Sang Kim is an Oral and Maxillofacial Surgeon practicing medicine in Mclean, Virginia. Dr. Kim is rated as an Experienced provider by MediFind in the treatment of Tongue Cancer. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Prognathism, Swallowing Difficulty, Tongue Cancer, Osteotomy, and Thyroidectomy.